TrialAntimicrobial agents and chemotherapy2010

Phase 2a study of the CCR5 monoclonal antibody PRO 140 administered intravenously to HIV-infected adults.

Jeffrey M Jacobson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.